BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 17875915)

  • 1. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
    Gan-Or Z; Giladi N; Rozovski U; Shifrin C; Rosner S; Gurevich T; Bar-Shira A; Orr-Urtreger A
    Neurology; 2008 Jun; 70(24):2277-83. PubMed ID: 18434642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
    Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations.
    Yahalom G; Rigbi A; Israeli-Korn S; Krohn L; Rudakou U; Ruskey JA; Benshimol L; Tsafnat T; Gan-Or Z; Hassin-Baer S; Greenbaum L
    J Parkinsons Dis; 2020; 10(3):1123-1132. PubMed ID: 32310186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
    Huang CL; Wu-Chou YH; Lai SC; Chang HC; Yeh TH; Weng YH; Chen RS; Huang YZ; Lu CS
    Eur J Neurol; 2011 Oct; 18(10):1227-32. PubMed ID: 21338444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
    Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L
    Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
    Alcalay RN; Dinur T; Quinn T; Sakanaka K; Levy O; Waters C; Fahn S; Dorovski T; Chung WK; Pauciulo M; Nichols W; Rana HQ; Balwani M; Bier L; Elstein D; Zimran A
    JAMA Neurol; 2014 Jun; 71(6):752-7. PubMed ID: 24756352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
    N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of severe vs mild GBA mutations on Parkinson disease.
    Gan-Or Z; Amshalom I; Kilarski LL; Bar-Shira A; Gana-Weisz M; Mirelman A; Marder K; Bressman S; Giladi N; Orr-Urtreger A
    Neurology; 2015 Mar; 84(9):880-7. PubMed ID: 25653295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Ross BM; Verbitsky M; Kisselev S; Louis ED; Comella C; Colcher A; Jennings D; Nance MA; Bressman SB; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Ottman R; Marder K; Clark LN
    Arch Neurol; 2010 Sep; 67(9):1116-22. PubMed ID: 20837857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
    Toft M; Pielsticker L; Ross OA; Aasly JO; Farrer MJ
    Neurology; 2006 Feb; 66(3):415-7. PubMed ID: 16476943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase mutations in Thai patients with Parkinson's disease.
    Pulkes T; Choubtum L; Chitphuk S; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):986-91. PubMed ID: 24997549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A
    Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.